1] Department of Human Genetics, Radboud Institute for Molecular Life Sciences and Donders Centre for Neuroscience, Radboud University Medical Center, Geert Grooteplein 10, 6525 GA Nijmegen, the Netherlands [2].
Department of Human Genetics, Radboud Institute for Molecular Life Sciences and Donders Centre for Neuroscience, Radboud University Medical Center, Geert Grooteplein 10, 6525 GA Nijmegen, the Netherlands.
Nature. 2014 Jul 17;511(7509):344-7. doi: 10.1038/nature13394. Epub 2014 Jun 4.
Severe intellectual disability (ID) occurs in 0.5% of newborns and is thought to be largely genetic in origin. The extensive genetic heterogeneity of this disorder requires a genome-wide detection of all types of genetic variation. Microarray studies and, more recently, exome sequencing have demonstrated the importance of de novo copy number variations (CNVs) and single-nucleotide variations (SNVs) in ID, but the majority of cases remain undiagnosed. Here we applied whole-genome sequencing to 50 patients with severe ID and their unaffected parents. All patients included had not received a molecular diagnosis after extensive genetic prescreening, including microarray-based CNV studies and exome sequencing. Notwithstanding this prescreening, 84 de novo SNVs affecting the coding region were identified, which showed a statistically significant enrichment of loss-of-function mutations as well as an enrichment for genes previously implicated in ID-related disorders. In addition, we identified eight de novo CNVs, including single-exon and intra-exonic deletions, as well as interchromosomal duplications. These CNVs affected known ID genes more frequently than expected. On the basis of diagnostic interpretation of all de novo variants, a conclusive genetic diagnosis was reached in 20 patients. Together with one compound heterozygous CNV causing disease in a recessive mode, this results in a diagnostic yield of 42% in this extensively studied cohort, and 62% as a cumulative estimate in an unselected cohort. These results suggest that de novo SNVs and CNVs affecting the coding region are a major cause of severe ID. Genome sequencing can be applied as a single genetic test to reliably identify and characterize the comprehensive spectrum of genetic variation, providing a genetic diagnosis in the majority of patients with severe ID.
严重智力障碍(ID)在新生儿中发生率为 0.5%,其病因主要被认为是遗传因素。这种疾病的广泛遗传异质性需要对所有类型的遗传变异进行全基因组检测。微阵列研究,以及最近的外显子组测序,已经证明了新生突变的拷贝数变异(CNVs)和单核苷酸变异(SNVs)在 ID 中的重要性,但大多数病例仍然无法诊断。在这里,我们对 50 名严重 ID 患者及其未受影响的父母进行了全基因组测序。所有纳入的患者在进行广泛的遗传预筛查后,包括基于微阵列的 CNV 研究和外显子组测序,均未获得分子诊断。尽管进行了这种预筛查,但仍鉴定出了 84 个影响编码区的新生 SNV,这些 SNV 显示出功能丧失突变的统计学显著富集,以及先前与 ID 相关疾病相关的基因富集。此外,我们还鉴定出了 8 个新生 CNV,包括单外显子和内含子缺失,以及染色体间重复。这些 CNV 比预期更频繁地影响已知的 ID 基因。基于对所有新生变异的诊断解释,在 20 名患者中得出了明确的遗传诊断。加上一个导致疾病的隐性模式的复合杂合 CNV,这使得在这个经过广泛研究的队列中,诊断率达到了 42%,而在未选择的队列中,累积估计值为 62%。这些结果表明,影响编码区的新生 SNV 和 CNV 是严重 ID 的主要原因。全基因组测序可以作为一种单一的遗传测试,可靠地识别和描述遗传变异的全面谱,为大多数严重 ID 患者提供遗传诊断。